[Acellular pertussis vaccine (Pa)].
Vaccination by whole-cell pertussis vaccine (Pw) since forties years was followed by decreasing of morbidity and especially mortality caused by pertussis. High reactogenicity of this vaccine (Pw) was the reason trials undertaken to search new type of less reactogenic vaccine.
openaire +1 more source
Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection. [PDF]
González FM +7 more
europepmc +1 more source
Corrigendum: <i>Brucella suis</i> Δ<i>mapB</i> outer membrane vesicles as an acellular vaccine against systemic and mucosal <i>B. suis</i> infection. [PDF]
González FM +7 more
europepmc +1 more source
Recommended immunization schedule for children and adolescents aged 18 years or younger, United States, 2018 [PDF]
\u2022 Consult relevant ACIP statements for detailed recommendations (www.cdc.gov/vaccines/hcp/acip-recs/index.html).\u2022 When a vaccine is not administered at the recommended age, administer at a subsequent visit.\u2022 Use combination vaccines ...
core
BackgroundIn 2012, over 48,000 pertussis cases were reported in the United States. Many cases occurred in vaccinated persons, showing that pertussis vaccination does not prevent all pertussis cases.
core
Acellular Pertussis Vaccines Have Arrived [PDF]
openaire +3 more sources
Sociodemographic Risk Factors for Incomplete Routine Childhood Immunizations Among Children Born During the COVID-19 Pandemic, Louisiana, March 1, 2020-July 1, 2021. [PDF]
Bakshi A +4 more
europepmc +1 more source
Pathogenicity and vaccine protection of circulating pertactin- and filamentous hemagglutinin-deficient <i>Bordetella pertussis</i> strains. [PDF]
Dai H +16 more
europepmc +1 more source
DTaP-induced infantile epileptic spasms syndrome high-risk window: Insights from school-age children. [PDF]
Zhang Q +15 more
europepmc +1 more source

